NIH Grant Awarded to Study Treatment for Crohn’s Disease

Trethera Corp., a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, has been awarded a $1.8 million National Institutes of Health (NIH) grant for preclinical studies of TRE515 as a Crohn’s disease treatment. TRE515 is a once-daily oral therapy that inhibits deoxycytidine kinase (dCK), an enzyme critical to the deoxyribonucleoside salvage […]

HHS Cuts Funding for mRNA Vaccine Research

The U.S. Department of Health and Human Services (HHS) has begun a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA).

New Data Show One in 31 Kids Has Autism

Autism prevalence in the U.S. has increased from one in 36 children to one in 31, according to the Centers for Disease Control and Prevention’s (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey.